JF
James C Foster (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Charles River Laboratories Inte (CRL). The largest single filing was $16.9M of CRL (75,000 sh × $225.00, as filed), executed Jun 29. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$43.3M
shares × price, as filed
Last traded
Oct 22
Filed Oct 26
Median ADV $249.8M across their filed names
Open performance→Volume by month
Buys $1.0M
Sells $43.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
CRL
Charles River Laboratories Inte
CRL · 1 buy · 4 sells
5 filings
Recent filings
CRLSALE
Charles River Laboratories Inte
View filing →
$8.4M24,042 sh × $350.00
Exec Oct 22
Filed Oct 26 · 4:51 PM ET CRLSALE Charles River Laboratories Inte View filing → $10.1M
33,561 sh × $300.00
Exec Aug 25
Filed Aug 27 · 4:21 PM ET CRLSALE Charles River Laboratories Inte View filing → $7.9M
28,733 sh × $275.00
Exec Aug 10
Filed Aug 11 · 4:35 PM ET CRLSALE Charles River Laboratories Inte View filing → $16.9M
75,000 sh × $225.00
Exec Jun 29
Filed Jul 1 · 4:59 PM ET CRLPURCHASE Charles River Laboratories Inte View filing → $1.0M
6,075 sh × $165.01
Exec Feb 20 2025
Filed Feb 21 2025 · 5:30 PM ET